Nutex Health Inc. (NASDAQ:NUTX)’s traded shares stood at 3.03 million during the last session, with the company’s beta value hitting 0.76. At the close of trading, the stock’s price was $1.07, to imply a decrease of -5.31% or -$0.06 in intraday trading. The NUTX share’s 52-week high remains $52.80, putting it -4834.58% down since that peak but still an impressive 53.27% since price per share fell to its 52-week low of $0.50. The company has a valuation of $847.90M, with an average of 1.94 million shares in intraday trading volume over the past 10 days and average of 1.52 million shares over the past 3 months.
Nutex Health Inc. (NASDAQ:NUTX) trade information
After registering a -5.31% downside in the last session, Nutex Health Inc. (NUTX) has traded red over the past five days. The stock hit a weekly high of 1.4850 this Wednesday, 03/15/23, dropping -5.31% in its intraday price action. The 5-day price performance for the stock is -27.21%, and -15.75% over 30 days. With these gigs, the year-to-date price performance is -43.68%. Short interest in Nutex Health Inc. (NASDAQ:NUTX) saw shorts transact 7.0 million shares and set a 3.18 days time to cover.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Nutex Health Inc. (NUTX) estimates and forecasts
Looking at statistics comparing Nutex Health Inc. share performance against respective industry, we note that the company has outperformed competitors. Nutex Health Inc. (NUTX) shares are -59.16% down over the last 6 months, with its year-to-date growth rate higher than industry average at 100.00% against 0.90%.
Revenue forecast for the current quarter as set by 1 analysts is $50.6 million. Meanwhile, for the quarter ending Mar 2023, a total of 1 analyst(s) estimate revenue growth to $65.4 million.
NUTX Dividends
Nutex Health Inc. has its next earnings report out between May 11 and May 15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Nutex Health Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Nutex Health Inc. (NASDAQ:NUTX)’s Major holders
Nutex Health Inc. insiders hold 50.48% of total outstanding shares, with institutional holders owning 1.48% of the shares at 2.98% float percentage. In total, 1.48% institutions holds shares in the company, led by Blackrock Inc. As of Sep 29, 2022, the company held over 1.64 million shares (or 0.25% of shares), all amounting to roughly $2.46 million.
The next major institution holding the largest number of shares is Creative Planning with 0.82 million shares, or about 0.13% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $1.23 million.
We also have iShares Russell 2000 ETF and iShares Russell 2000 Growth ETF as the top two Mutual Funds with the largest holdings of the Nutex Health Inc. (NUTX) shares. Going by data provided on Dec 30, 2022, iShares Russell 2000 ETF holds roughly 5.32 million shares. This is just over 0.82% of the total shares, with a market valuation of $10.11 million. Data from the same date shows that the other fund manager holds a little less at 2.07 million, or 0.32% of the shares, all valued at about 3.92 million.
